David Foley

627 total citations
18 papers, 500 citations indexed

About

David Foley is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Foley has authored 18 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Foley's work include Drug Transport and Resistance Mechanisms (5 papers), Cancer-related Molecular Pathways (3 papers) and Chemical Synthesis and Analysis (2 papers). David Foley is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Cancer-related Molecular Pathways (3 papers) and Chemical Synthesis and Analysis (2 papers). David Foley collaborates with scholars based in United Kingdom, Australia and United States. David Foley's co-authors include David Meredith, Myrtani Pieri, Patrick D. Bailey, Hao Shao, Shudong Wang, Shi‐Liang Huang, Frankie Lam, Peter M. Fischer, Xiangrui Liu and Julie Affleck and has published in prestigious journals such as The Journal of Physiology, Journal of Medicinal Chemistry and European Journal of Cancer.

In The Last Decade

David Foley

17 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Foley United Kingdom 11 212 151 101 100 62 18 500
Jean‐Philippe Annereau France 12 323 1.5× 116 0.8× 86 0.9× 32 0.3× 25 0.4× 17 468
Kateryna Kondratska France 11 333 1.6× 75 0.5× 64 0.6× 33 0.3× 33 0.5× 12 622
Kenneth Huang United States 13 454 2.1× 43 0.3× 190 1.9× 77 0.8× 9 0.1× 20 623
Xundi Xu China 13 424 2.0× 130 0.9× 19 0.2× 38 0.4× 58 0.9× 31 718
Kaltoom Al‐Sakkaf United Kingdom 10 254 1.2× 129 0.9× 19 0.2× 14 0.1× 33 0.5× 14 427
Milena Pervan United States 6 317 1.5× 204 1.4× 22 0.2× 30 0.3× 106 1.7× 8 768
Cheryl A. Grice United States 12 347 1.6× 41 0.3× 167 1.7× 17 0.2× 15 0.2× 21 665
Taisuke Matsuo Japan 15 366 1.7× 91 0.6× 139 1.4× 16 0.2× 64 1.0× 68 707
James I. Fells United States 18 717 3.4× 64 0.4× 61 0.6× 20 0.2× 14 0.2× 27 848
Shifang Peng China 14 323 1.5× 124 0.8× 67 0.7× 28 0.3× 24 0.4× 44 683

Countries citing papers authored by David Foley

Since Specialization
Citations

This map shows the geographic impact of David Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Foley more than expected).

Fields of papers citing papers by David Foley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Foley. The network helps show where David Foley may publish in the future.

Co-authorship network of co-authors of David Foley

This figure shows the co-authorship network connecting the top 25 collaborators of David Foley. A scholar is included among the top collaborators of David Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Foley. David Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Baldwin, Alex G., David Foley, Hyun-Ah Lee, et al.. (2025). Tetrahydropyrazolopyridinones as a Novel Class of Potent and Highly Selective LIMK Inhibitors. Journal of Medicinal Chemistry. 68(16). 17427–17456.
2.
Lee, Hyun-Ah, Jonathan M. Elkins, Carys Thomas, et al.. (2022). Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity. Journal of Medicinal Chemistry. 65(20). 13705–13713. 10 indexed citations
3.
Shao, Hao, David Foley, Shi‐Liang Huang, et al.. (2021). Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents. European Journal of Medicinal Chemistry. 214. 113244–113244. 18 indexed citations
4.
Foley, David, et al.. (2020). True or false? Challenges and recent highlights in the development of aspirin prodrugs. European Journal of Medicinal Chemistry. 192. 112200–112200. 17 indexed citations
5.
Foley, David, C.E. Naylor, G M Wood, et al.. (2019). Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1). ACS Medicinal Chemistry Letters. 10(3). 341–347. 7 indexed citations
6.
Foley, David, C.E. Naylor, Colin Robinson, et al.. (2018). Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1. Bioorganic & Medicinal Chemistry Letters. 28(19). 3255–3259. 19 indexed citations
7.
Foley, David, et al.. (2018). Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery. European Journal of Medicinal Chemistry. 156. 180–189. 15 indexed citations
8.
Foley, David, et al.. (2017). Demystifying automotive safety and security for semiconductor developer. 8 indexed citations
9.
Foley, David, Isabel Bermúdez, Patrick D. Bailey, & David Meredith. (2016). A cyclosporine derivative is a substrate of the oligopeptide transporter PepT1. MedChemComm. 7(5). 999–1002. 4 indexed citations
10.
Shao, Hao, David Foley, Frankie Lam, et al.. (2013). Synthesis, structure–activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents. European Journal of Medicinal Chemistry. 70. 447–455. 50 indexed citations
11.
Assefnia, Shahin, Sivanesan Dakshanamurthy, Jaime M. Guidry Auvil, et al.. (2013). Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies. Oncotarget. 5(6). 1458–1474. 52 indexed citations
12.
Shao, Hao, Shi‐Liang Huang, Alison J. Hole, et al.. (2013). Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer Activities. Journal of Medicinal Chemistry. 56(3). 640–659. 104 indexed citations
13.
Shao, Hao, Samuel Shi, David Foley, et al.. (2012). 274 Synthesis and in Vitro Evaluation of Selective CDK9 Inhibitors. European Journal of Cancer. 48. 84–84. 1 indexed citations
14.
Foley, David, Jeyaganesh Rajamanickam, Patrick D. Bailey, & David Meredith. (2010). Bioavailability Through PepT1: The Role of Computer Modelling in Intelligent Drug Design. Current Computer - Aided Drug Design. 6(1). 68–78. 29 indexed citations
15.
Foley, David, Patrick D. Bailey, Myrtani Pieri, & David Meredith. (2009). Targeting ketone drugs towards transport by the intestinal peptide transporter, PepT1. Organic & Biomolecular Chemistry. 7(6). 1064–1064. 14 indexed citations
16.
Foley, David, et al.. (2009). The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1. Organic & Biomolecular Chemistry. 7(18). 3652–3652. 17 indexed citations
17.
Mace, Oliver J., Norma Lister, Julie Affleck, et al.. (2008). An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine. The Journal of Physiology. 587(1). 195–210. 132 indexed citations
18.
Camenzind, Edoardo, Willem H. Bakker, Ambroos E.M. Reijs, et al.. (1997). Site-specific intravascular administration of drugs: History of a method applicable in humans. Catheterization and Cardiovascular Diagnosis. 41(3). 342–347. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Philippe Annereau Breakdown of academic impact, for papers by Kateryna Kondratska Breakdown of academic impact, for papers by Kenneth Huang Breakdown of academic impact, for papers by Xundi Xu Breakdown of academic impact, for papers by Kaltoom Al‐Sakkaf Breakdown of academic impact, for papers by Milena Pervan Breakdown of academic impact, for papers by Cheryl A. Grice Breakdown of academic impact, for papers by Taisuke Matsuo Breakdown of academic impact, for papers by James I. Fells Breakdown of academic impact, for papers by Shifang Peng
Rankless by CCL
2026